Booster vaccinations reduced risk of death from COVID-19 in 2022 Booster vaccinations reduced the risk of dying from COVID-19 in 2022. The risk of death from other causes was also lower for people who had a booster jab than for people without a booster jab. These findings are from research by RIVM.
COVID-19 pandemic made me miss out on a key stage of my life, young people claim Young people aged 12–25 feel that the COVID-19 pandemic made them miss out on a key stage of their lives. They have indicated that important milestones, such as graduation ceremonies or the start of student life, passed them by. This is evident from the latest quarterly study conducted by the Network for Health Research in Disasters.
Perceived health impact of COVID-19 pandemic differs widely among vulnerable people The health impact of the COVID-19 pandemic and the associated measures is perceived very differently by vulnerable groups in society.
Half of post-traumatic stress disorder related to pandemic In autumn 2022, 3.7% of adults in the Netherlands were suffering from suspected post-traumatic stress disorder (PTSD).
Model for projecting COVID-19 hospital and ICU admissions, complete with code RIVM has published the code for model projections of COVID-19 hospital and ICU admissions. The code has been shared as part of a manuscript about the model.
First clients and care workers in mental healthcare vaccinated on Monday The first mental health clients in inpatient or residential care in four large institutions in the Netherlands will be vaccinated against COVID-19 this week.
New research in GGD test lanes on spread of coronavirus SARS-CoV-2 RIVM is launching a survey-based study this week on risk factors for the coronavirus SARS-CoV-2. The participants in this study are people who get tested for COVID-19 in a GGD test lane.
New variants disrupt plans In the past week, from 27 January to 2 February, 28,628 people in the Netherlands reportedly tested positive for COVID-19, a 20% decrease compared to the week of 20 to 26 January.
One person died shortly after COVID-19 vaccination The Pharmacovigilance Centre Lareb announced today that the centre had received a report of death shortly after receiving the Pfizer/BioNTech COVID-19 vaccination in the Netherlands.
Nationwide assessment of SARS-CoV-2 laboratories: very high quality The vast majority of the laboratories analysing COVID-19 tests are performing at the very highest standard of quality.